Abnormality of Stature in Children: Short Stature, Tall Stature Causes and Management
Paediatrics

Abnormality of Stature in Children: Short Stature, Tall Stature Causes and Management


Abnormality of Stature (Growth Disorders) — Full Detail

1. Definition

Stature refers to a child’s height/length compared with age- and sex-matched norms.

Abnormal stature includes:

  • Short stature: Height < –2 SD or below 3rd percentile
  • Tall stature: Height > +2 SD or above 97th percentile
  • Growth failure: Poor height velocity over time

2. Normal Growth Physiology

Growth depends on:

  • Genetics
  • Nutrition
  • Endocrine hormones

* Growth hormone (GH)

* Thyroid hormone

* Sex steroids

  • Chronic disease status
  • Psychosocial environment

3. Classification of Abnormal Stature

A. Short Stature

  1. Normal variant
  2. Pathological causes
  3. Syndromic causes

B. Tall Stature

  1. Familial tall stature
  2. Endocrine excess
  3. Genetic syndromes

SHORT STATURE — COMPLETE DETAIL

4. Definition

Short stature is:

  • Height < 3rd percentile OR
  • Height < –2 SD for age/sex OR
  • Growth velocity below expected

5. Causes of Short Stature


A. Normal Variants (Non-pathologic)

1. Familial Short Stature

  • Parents are short
  • Child grows normally along low percentile
  • Bone age = chronological age
  • Puberty normal

2. Constitutional Delay of Growth and Puberty (CDGP)

  • Delayed puberty
  • Bone age delayed
  • Growth velocity normal
  • Family history of “late bloomers”

B. Endocrine Causes

1. Growth Hormone Deficiency

  • Poor growth velocity
  • Increased fat mass
  • Immature face
  • Delayed bone age

2. Hypothyroidism

  • Short stature with weight gain
  • Lethargy, constipation
  • Delayed bone age

3. Cushing Syndrome

  • Growth failure with obesity
  • Moon face, striae

C. Chronic Systemic Diseases

  • Chronic kidney disease
  • Congenital heart disease
  • Malabsorption (celiac disease)
  • Chronic infection (TB, HIV)

Clue: Weight affected before height


D. Malnutrition

  • Commonest cause worldwide
  • Both weight and height reduced

E. Genetic and Syndromic Causes

Turner Syndrome (Girls)

  • Short stature
  • Webbed neck
  • Amenorrhea
  • XO karyotype

Down Syndrome

  • Short stature with dysmorphic features

Skeletal Dysplasias

  • Achondroplasia (disproportionate short stature)

F. Intrauterine Growth Restriction (IUGR)

  • Small for gestational age
  • Failure of catch-up growth

6. Clinical Evaluation of Short Stature


History

  • Birth weight/length
  • Growth pattern since infancy
  • Nutrition and feeding
  • Chronic illness symptoms
  • Family height history
  • Puberty timing

Examination

  • Accurate height measurement
  • Body proportions:

* Upper segment/lower segment ratio

* Arm span

  • Dysmorphic features
  • Pubertal staging (Tanner)
  • Signs of systemic disease

Growth Velocity

Normal height velocity:

  • 0–1 yr: ~25 cm/year
  • 1–2 yr: ~12 cm/year
  • 2–4 yr: ~7 cm/year
  • Childhood: 5–6 cm/year
  • Puberty: 8–12 cm/year

7. Investigations


Baseline Tests

  • CBC (anemia, chronic disease)
  • ESR/CRP (inflammation)
  • Renal and liver function
  • Celiac screen (tTG IgA)
  • Thyroid profile (TSH, FT4)

Bone Age

X-ray left hand/wrist:

  • Delayed → endocrine/CDGP
  • Normal → familial short stature
  • Advanced → precocious puberty

Hormonal Tests

  • IGF-1 and IGFBP-3
  • GH stimulation test (if suspected deficiency)

Genetic Tests

  • Karyotype in girls (Turner syndrome)

8. Management of Short Stature


A. Treat Underlying Cause

  • Nutrition rehabilitation
  • Treat chronic disease
  • Thyroxine for hypothyroidism
  • Gluten-free diet for celiac

B. Growth Hormone Therapy

Indications

  • GH deficiency
  • Turner syndrome
  • Chronic renal failure
  • Prader-Willi syndrome
  • Idiopathic short stature (selected)

Drug: Somatropin (Recombinant GH)

  • Mechanism: Stimulates IGF-1 → growth plate proliferation
  • Dose: 0.025–0.05 mg/kg/day SC
  • Adverse effects:

* Intracranial hypertension

* Slipped capital femoral epiphysis

* Hyperglycemia

  • Monitoring:

* Growth velocity

* IGF-1 levels

* Thyroid function


C. Puberty Induction (CDGP severe cases)

  • Low-dose testosterone (boys)
  • Estrogen therapy (girls)

TALL STATURE — COMPLETE DETAIL


9. Definition

Tall stature:

  • Height > 97th percentile or > +2 SD

10. Causes of Tall Stature


A. Normal Variants

Familial Tall Stature

  • Parents tall
  • Normal growth velocity
  • Bone age normal/slightly advanced

B. Endocrine Causes

1. Growth Hormone Excess (Gigantism)

  • Rapid growth velocity
  • Coarse facial features
  • Enlarged hands/feet

2. Hyperthyroidism

  • Increased growth rate
  • Weight loss, tremors

3. Precocious Puberty

  • Tall initially but short adult height due to early epiphyseal closure

C. Genetic Syndromes

Marfan Syndrome

  • Tall, long limbs
  • Arm span > height
  • Lens dislocation
  • Aortic dilation

Klinefelter Syndrome (XXY)

  • Tall males
  • Small testes, infertility

Sotos Syndrome

  • Cerebral gigantism
  • Developmental delay

11. Evaluation of Tall Stature

  • Growth velocity trend
  • Bone age
  • Puberty status
  • Dysmorphic features
  • IGF-1 level if GH excess suspected

12. Management of Tall Stature

  • Reassurance in familial cases
  • Treat endocrine disorders:

* GH tumor surgery/medical therapy

* Antithyroid drugs

  • Precocious puberty: GnRH analogs

13. Red Flags (Urgent Referral)

  • Growth velocity falling rapidly
  • Height crossing percentiles downward
  • Dysmorphism
  • Delayed or absent puberty
  • Neurologic symptoms (headache, vision changes)

Summary Table

| Condition | Bone Age | Growth Velocity | Key Feature |

| ---------------------- | ----------------------- | --------------- | ---------------- |

| Familial short stature | Normal | Normal | Short parents |

| CDGP | Delayed | Normal | Late puberty |

| GH deficiency | Delayed | Low | Increased fat |

| Hypothyroidism | Delayed | Low | Weight gain |

| Chronic disease | Normal/slightly delayed | Low | Poor weight gain |

| Familial tall stature | Normal | Normal | Tall parents |

| GH excess | Advanced | High | Coarse features |

| Marfan | Normal | Normal/high | Long limbs |


Interactive MCQ Quiz

MCQ Exam Mode

15 Questions
Question 1 of 15

Frequently Asked Questions

Abnormality of stature refers to deviation of a child’s height from the normal range for age and sex. It includes short stature (height below the 3rd percentile or < –2 SD) and tall stature (height above the 97th percentile or > +2 SD).
Short stature is defined as height less than the 3rd percentile or more than 2 standard deviations below the mean for age and sex, or when growth velocity is significantly reduced.
The most common cause of short stature worldwide is malnutrition, which leads to impaired linear growth due to inadequate caloric and protein intake.
Normal variants include familial short stature (genetic short parents, normal bone age) and constitutional delay of growth and puberty (delayed bone age, late puberty but normal final height).
Familial short stature has normal bone age equal to chronological age, while constitutional delay shows delayed bone age and delayed puberty with eventual catch-up growth.
Endocrine causes include growth hormone deficiency, hypothyroidism, Cushing syndrome, and poorly controlled diabetes mellitus.
Features include poor growth velocity, delayed bone age, increased truncal fat, immature facial appearance, and sometimes hypoglycemia in infancy.
Thyroid hormone is essential for growth plate maturation. Deficiency leads to reduced growth velocity, delayed skeletal maturation, and short stature.
Chronic diseases like renal failure, congenital heart disease, tuberculosis, and inflammatory bowel disease impair growth, typically with weight loss occurring before height impairment.
Turner syndrome, Down syndrome, Noonan syndrome, and skeletal dysplasias such as achondroplasia are important genetic causes.
Turner syndrome should be suspected when short stature is associated with webbed neck, shield chest, widely spaced nipples, delayed puberty, or primary amenorrhea.
Bone age is assessed by X-ray of the left hand and wrist. It helps differentiate normal variants (familial short stature) from endocrine disorders or constitutional delay.
Delayed bone age suggests constitutional delay of growth and puberty, growth hormone deficiency, hypothyroidism, or chronic systemic illness.
Advanced bone age is typically seen in precocious puberty, hyperthyroidism, congenital adrenal hyperplasia, or androgen excess states.
Baseline workup includes CBC, ESR/CRP, renal and liver function tests, thyroid function tests, celiac serology, and bone age assessment.
Tall stature is defined as height above the 97th percentile or more than +2 standard deviations above the mean for age and sex.
Causes include familial tall stature, growth hormone excess (gigantism), hyperthyroidism, precocious puberty, and genetic syndromes such as Marfan syndrome and Klinefelter syndrome.
Gigantism presents with excessive growth velocity, coarse facial features, enlarged hands and feet, elevated IGF-1, and often pituitary adenoma symptoms such as headache or visual defects.
Red flags include rapid crossing of growth percentiles, very low growth velocity, dysmorphic features, delayed or absent puberty, neurological symptoms, and suspicion of systemic disease.
Growth hormone therapy is indicated in GH deficiency, Turner syndrome, chronic renal failure, Prader-Willi syndrome, children born small for gestational age without catch-up growth, and selected idiopathic short stature cases.
Adverse effects include intracranial hypertension, slipped capital femoral epiphysis, worsening scoliosis, hyperglycemia, and edema, requiring careful monitoring.
Management depends on identifying the underlying cause, addressing nutrition and chronic illness, treating endocrine disorders, considering growth hormone therapy when appropriate, and monitoring growth velocity and pubertal development.